Textbook versus reality
Watch the walkthrough
Can't play video on a trust computer? Everything in the videos is covered in the notes below.
What to actually do at 3am
ECG changes at any potassium level mean IV calcium first. Severity then decides how much more you do and how quickly you escalate (UK Kidney Association, 2026).
Find and treat the cause, review medicines, recheck. Emergency drugs aren't usually needed unless the ECG shows changes.
Urgent 12-lead ECG. Consider insulin–glucose and a potassium binder. Cardiac monitor if unwell or the potassium is rising fast.
Emergency. Cardiac monitor, insulin–glucose with salbutamol, start SZC, and tell your registrar now.
Is it real? Go and see the patient
- ABCDE assessment and NEWS2. If they're peri-arrest, put out a 2222 call.
- Get a 12-lead ECG now for any potassium ≥6.0. Look for peaked T waves, a widening QRS, flattened P waves or bradycardia.
- Send a blood gas while you wait. Its potassium result comes back in minutes.
- Suspect pseudohyperkalaemia (haemolysis, delayed sample)? Repeat it from a large vein with minimal tourniquet time and analyse it promptly. Consider paired lithium heparin and clotted samples.
- If the ECG shows changes, treat now. Don't wait for the repeat sample.
Protect the heart (if the ECG has changed)
- Calcium gluconate 10%, 30 mL IV over 10 minutes. In cardiac arrest or peri-arrest, use calcium chloride 10%, 10 mL IV over 5 minutes.
- Use a good cannula and check it flushes, because calcium causes tissue injury if it extravasates. Don't run it in the same line as bicarbonate.
- Repeat the ECG afterwards. Consider a further dose if the changes persist. The effect lasts about 60 minutes.
- Calcium buys you time but doesn't lower the potassium.
Shift potassium into the cells
- Insulin–glucose: 10 units of soluble insulin with 25 g of glucose IV. Recommended at ≥6.5; can be used at 6.0–6.4.
- Check capillary glucose first. If it's below 7.0 mmol/L, follow with 10% glucose at 50 mL/hour for 5 hours.
- Check glucose at 0, 30, 60, 90, 120, 180, 240, 300 and 360 minutes. Late hypoglycaemia is the one that gets missed overnight.
- Salbutamol 10–20 mg nebulised as an add-on for K⁺ ≥6.5. Never use it on its own. Use a lower dose, with monitoring, in cardiac disease.
- IV sodium bicarbonate isn't routine. It's reserved for hyperkalaemic cardiac arrest.
Remove potassium and fix the cause
- Sodium zirconium cyclosilicate (SZC): recommended at ≥6.5 and considered at 6.0–6.4. Patiromer is an alternative at ≥6.0 (NICE, 2019, 2020).
- Calcium resonium no longer has a role in acute treatment.
- Stop or hold culprits: potassium supplements, ACE inhibitors/ARBs, spironolactone, NSAIDs, trimethoprim.
- Look for AKI: fluid status, urine output, bladder scan or catheter if retention is possible.
- Dialysis decisions belong to the renal or critical care team. Haemodialysis patients with severe hyperkalaemia need urgent dialysis.
Recheck, and keep rechecking
- Recheck potassium at least at 1, 2, 4, 6 and 24 hours after moderate or severe hyperkalaemia.
- Not below 6.0 mmol/L within 2 hours? Consider another round of insulin–glucose and get specialist advice.
- Watch for rebound as the shifting treatments wear off.
Exactly how to write it up
If your trust has an electronic order set or a pre-printed hyperkalaemia protocol, use it. This is how the drugs typically land on the chart.
| Drug | Dose | Route · rate | Where on the chart | Watch for |
|---|---|---|---|---|
| Calcium gluconate 10% | 30 mL | IV over 10 min | Once-only | Only if ECG changes. Repeat ECG afterwards. |
| Insulin–glucose Soluble insulin (e.g. Actrapid) with glucose 25 g | 10 units insulin — write "units" in full + 25 g glucose: 50 mL of 50%, 125 mL of 20% or 250 mL of 10% | IV, given together over 15 min | Prescribed together — use your trust's combined order set or protocol if there is one | Check CBG first. Insulin syringe only; two-person check. 50% glucose carries an extravasation risk, so many trusts prefer 20% or 10%. |
| Glucose 10% | 50 mL/hour for 5 hours | IV infusion | Infusion / fluid chart | Only if pre-treatment CBG is below 7.0 mmol/L. Titrate to CBG 4–7. |
| Salbutamol | 10–20 mg | Nebulised | Once-only | Add-on only. Lower dose in cardiac disease. |
| Sodium zirconium cyclosilicate | 10 g three times daily | Oral, up to 72 hours | Regular | Review daily and stop once potassium is controlled. |
Organising the team
Tip: write the actual clock times for each potassium and glucose check on the obs chart and your handover list, e.g. "K⁺ 03:15, 04:15, 06:15, 08:15".
When to call for help
Common pitfalls
- Dismissing a "haemolysed" result without repeating it.
- Giving salbutamol alone for severe hyperkalaemia.
- Stopping glucose checks too early and missing a late hypo.
- Treating the number, then forgetting to recheck it.
- Not finding the cause: drugs, AKI, retention, tissue breakdown.
- Writing "U" or "IU" for insulin units.
Documenting it (example)
For illustration purposes only. Please don't copy and paste this. Document the details relevant to the patient you are assessing.
Called re K⁺ 6.8 (lab, not haemolysed). Seen 02:10. A–E stable, NEWS2 1. ECG: peaked T, QRS 130 ms. Given: Ca gluconate 10% 30 mL IV 02:20. Insulin 10 units + 25 g glucose IV 02:25. Pre-CBG 6.1 → 10% glucose 50 mL/h for 5 h. SZC 10 g TDS started. Salbutamol 10 mg neb. Cause: ?AKI + ramipril/spironolactone — both held. Plan: K⁺ 1, 2, 4, 6, 24 h. CBG per schedule. Cardiac monitor. D/w medical registrar 02:30. Re-review: 03:30 with 1 h K⁺ result (sooner if concerned).
Test yourself
Take it to the ward
One-page checklist
The five steps as a tick-box checklist with exact doses, boxes to write in your potassium recheck times, and when to call for help, all on a single A4 page. Print it, or keep it on your phone.
PDF · 1 page · A4 · 140 KBRead further
DISCLAIMERAlways refer to your own Trust's hyperkalaemia guideline. Where it differs from the references below, follow your Trust guideline.
- Joint Formulary Committee (2026) British National Formulary. Available at: https://bnf.nice.org.uk (Accessed: 18 November 2026).
- National Institute for Health and Care Excellence (NICE) (2019) Sodium zirconium cyclosilicate for treating hyperkalaemia (Technology appraisal guidance TA599). Available at: https://www.nice.org.uk/guidance/ta599 (Accessed: 18 November 2026).
- National Institute for Health and Care Excellence (NICE) (2020) Patiromer for treating hyperkalaemia (Technology appraisal guidance TA623). Available at: https://www.nice.org.uk/guidance/ta623 (Accessed: 18 November 2026).
- Resuscitation Council UK (2025) Special circumstances guidelines. Available at: https://www.resus.org.uk/professional-library/2025-resuscitation-guidelines/special-circumstances-guidelines (Accessed: 18 November 2026).
- UK Kidney Association (2026) Clinical practice guideline: management of hyperkalaemia in adults. Updated July 2026. Available at: https://www.ukkidney.org/sites/default/files/documents/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20UPDATED%20JULY%202026_0.pdf (Accessed: 18 November 2026).